Novel Coronavirus (SARS-CoV-2/COVID-19)

The Food and Drug Administration authorized emergency use of a rapid point-of-care antigen test to detect SARS-CoV-2 directly from nasal swab specimens.
AHA President and CEO Rick Pollack discusses the COVID-19 pandemic and its impact on hospitals with former CNN anchor Frank Sesno, director of The George Washington University School of Media and Public Affairs and host of the Healthy You: Surviving a Pandemic podcast series.
Saint Peter's University Hospital in New Brunswick, New Jersey, created a specialized COVID-19 Recovery Program to treat patients who have recovered from COVID-19 but continue to experiene long-term symptoms.
The Centers for Disease Control and Prevention released a study examining how COVID-19 is affecting American Indians and Alaska Natives — one of the populations at highest risk for the disease.
The Department of Health and Human Services amended the declaration under the Public Readiness and Emergency Preparedness Act to authorize state-licensed pharmacists and pharmacy interns under their supervision to order and administer vaccines to children, subject to certain requirements.
The Food and Drug Administration released a resource to help U.S. health care providers select respirators for their health care facility.
The National Institute for Occupational Safety and Health released a report summarizing the particulate filtration efficiency of non-NIOSH-approved N95 respirators made in other countries and authorized for emergency use during the COVID-19 public health emergency.
The AHA urged President Trump and the Department of Health and Human Services to continue to act on behalf of hospitals and health systems by further expanding telehealth flexibilities.
The AHA unveiled the latest component of the association’s Wear A Mask initiative, with new content and collaborations to share resources and amplify key public health messages to stop the spread of COVID-19.